RECRUITINGOBSERVATIONAL

Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes

The Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes: A Prospective Study

About This Trial

The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad. The main questions it aims to answer are: How do pre-hospital delays (e.g., patient transport and first medical contact) affect clinical outcomes such as mortality, complication rates, and recovery time in MI patients? What is the influence of hospital-related delays (e.g., time to intervention or reperfusion therapy) on the prognosis of MI patients? Participants will: Be monitored for the time elapsed from symptom onset to first medical contact and subsequent time intervals during hospital care. Have their clinical outcomes, including in-hospital mortality, length of stay, and post-intervention complications, recorded and analyzed.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients who provide willing to sign a consent form (or a legal representative provides consent if the patient is unable to do so). - Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI). - Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset. Who Should NOT Join This Trial: - Patients with non-acute myocardial infarction (e.g., stable angina, prior MI). - Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols. - Patients who are transferred to another facility before reperfusion therapy is initiated. - Pregnant women or breastfeeding women. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so). * Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI). * Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset. Exclusion Criteria: * Patients with non-acute myocardial infarction (e.g., stable angina, prior MI). * Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols. * Patients who are transferred to another facility before reperfusion therapy is initiated. * Pregnant women or breastfeeding women.

Locations (1)

College of Medicine - Al-Nahrain University

Baghdad, Iraq